Characteristic | Drug A, N = 981 | Drug B, N = 1021 |
Age, yrs | 46 (37, 59) | 48 (39, 56) |
Unknown | 7 | 4 |
Marker Level, ng/mL | 0.84 (0.24, 1.57) | 0.52 (0.19, 1.20) |
Unknown | 6 | 4 |
T Stage | ||
T1 | 28 (29%) | 25 (25%) |
T2 | 25 (26%) | 29 (28%) |
T3 | 22 (22%) | 21 (21%) |
T4 | 23 (23%) | 27 (26%) |
Grade | ||
I | 35 (36%) | 33 (32%) |
II | 32 (33%) | 36 (35%) |
III | 31 (32%) | 33 (32%) |
Tumor Response | 28 (29%) | 33 (34%) |
Unknown | 3 | 4 |
Patient Died | 52 (53%) | 60 (59%) |
Months to Death/Censor | 23.5 (17.4, 24.0) | 21.2 (14.6, 24.0) |
1Statistics presented: median (IQR); n (%) | ||